Thrombosis of a cardiopulmonary bypass circuit despite recommended hypocoagulation with danaparoid during the acute phase of type II heparin-induced thrombocytopenia;Thrombose d'un circuit de circulation extracorporelle sous danaparoïde sodique à la phase aiguë d'une thrombopénie induite par l'héparine de type II en dépit d'une hypocoagulation recommandée

Annales Francaises d'Anesthesie et de Reanimation

Volumn 25, Issue 11-12, 2006, Pages 1144-1148

  Salmi, L ^a   Elalamy, I ^b   Leroy Matheron, C ^a   Houel, R ^a   Thebert D ^a   Duvaldestin, P ^a  

^a HENRI MONDOR HOSPITAL   (France)

^b HÔTEL DIEU   (France)

Author keywords

Cardiopulmonary bypass; Danaparoid; Thromocytopenia

Indexed keywords

ANTIVITAMIN K; BLOOD CLOTTING FACTOR 10A; DANAPAROID; FLUINDIONE; HEPARIN;

ADULT; ANTICOAGULATION; ARTICLE; CARDIOPULMONARY BYPASS; CASE REPORT; CEREBROVASCULAR ACCIDENT; CLINICAL FEATURE; DISEASE COURSE; HEART TUMOR; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; RECURRENCE RISK; STROKE; THROMBOSIS; TREATMENT OUTCOME;

ADULT; ANTICOAGULANTS; CARDIOPULMONARY BYPASS; CHONDROITIN SULFATES; DERMATAN SULFATE; FACTOR XA; FEMALE; HEPARIN; HEPARITIN SULFATE; HUMANS; THROMBOCYTOPENIA; THROMBOSIS;

EID: 33845490235     PISSN: 07507658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annfar.2004.11.003     Document Type: Article

References (22)

1. Elalamy I., Lecrubier C., Horellou M.H., Conard J., and Samama M.M. Heparin-induced thrombocytopenia: laboratory diagnosis and management. Ann. Med. 32 Suppl 1 (2000) 60-67
2. Chong B.H. Heparin-induced thrombocytopenia. Br. J. Haematol. 89 (1995) 431-439
3. Warkentin T.E. Heparin induced thrombocytopenia and the anaesthesiologist. Can. J. Anesth. 49 (2002) S36-S49
4. Doherty D.C., Ortel T.L., de Bruijn N., Greenberg C.S., and Van Trigt III P. "Heparin-free" cardiopulmonary bypass: first reported use of heparinoid (Org 10172) to provide anticoagulation for cardiopulmonary bypass. Anesthesiology 73 (1990) 562-565
5. Magnani H.N. Heparin-associated thrombocytopenia (HIT): an overview of 230 patients treated with Orgaran (ORG 10172). Thromb Haemosth 70 (1993) 554-561
6. Warkentin T.E., Dunn G.L., and Cybulsky I.J. Off pump coronary artery bypass grafting for acute heparin-induced thrombocytopenia. Ann. Thorac. Surg. 72 (2001) 1730-1732
7. Salmi L., Leroy-Matheron C., LeBesnerais P., Rosanval O., and Duvaldestin P. Gouault-Heilmann. Circulation extracorporelle sous danaparoïde sodique pour remplacement valvulaire au cours d'une thrombopénie induite par l'héparine de type II. Ann. Fr. Anesth. Réanim 20 (2001) 799-802
8. Nutall G.A., Oliver Jr. W.C., Santrach P.J., McBane R.D., Erpelding D.B., Marver C.L., et al. Patients with a history of type II heparin induced thrombocytopenia with thrombosis requiring cardiac surgery with cardiopulmonary bypass: a prospective observational case series. Anesth. Analg. 96 (2003) 344-350
9. Wilhelm M.J., Schmid C., Kececioglu D., Mollhoff T., Ostermann H., and Scheld H.H. Cardiopulmonary bypass in patients with heparin-induced thrombocytopenia using Org 10172. Ann. Thorac. Surg. 61 (1996) 920-924
10. Fernandes P., Mayer R., MacDonald J.L., Kleeland A.G., and Hay-McKay C. Use of danaparoid sodium (Orgaran) as an alternative to heparin sodium during cardiopulmonary bypass: a clinical evaluation of six cases. Perfusion 15 (2000) 531-539
11. Grocott H.P., Root J., Berkowitz S.D., De Bruijn N., and Landolfo K. Coagulation complicating cardiopulmonary bypass in a patient with heparin-induced thrombocytopenia receiving the heparinoid, danaparoid sodium. J. Cardiothorac. Vasc. Anesth. 11 (1997) 875-877
12. Gillis S., Merin G., Zahger D., Deeb M., Drenger B., Hyam E., et al. Danaparoid for cardiopulmonary bypass in patients with previous heparin-induced thrombocytopenia. Br. J. Haematol. 98 (1997) 657-659
13. Koster A., Meyer O., Fischer T., Kukucka M., Krabatsch T., Bauer M., et al. One-year experience with the platelet glycoprotein IIb/IIIa antagonist tirofiban and heparin during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II. J. Thorac. Cardiovasc. Surg. 122 (2001) 1254-1255
14. Von Segesser L.K., Mueller X., Marty B., Horisberger J., and Corno A. Alternatives to unfractionated heparin for anticoagulation in cardiopulmonary bypass. Perfusion 16 (2001) 411-416
15. Pineau E., LeBret E., Folliguet T., Saint-Maurice O., Carbognani D., and Laborde F. Utilisation de l'Orgaran, héparinoïde de synthèse, lors de deux circulations extracorporelles, chez un même patient allergique à l'héparine. Arch. Mal du Cœur 94 (2001) 144-147
16. Blanloeil Y., and Janvier G. Thrombopénie induite par l'héparine : réflexions à propos d'une conférence d'experts. Ann. Fr. Anesth. Réanim. 22 (2003) 88-90
17. Follis F., and Schmidt C.A. Cardiopulmonary bypass in patients with heparin-induced thrombocytopenia and thrombosis. Ann. Thorac. Surg. 70 (2000) 2173-2181
18. Stamou S.C., and Corson P.J. Coronary revascularization without cardiopulmonary bypass in high-risk patients: a route to the future. Ann. Thorac. Surg. 71 (2001) 1056-1061
19. Warkentin T.E., and Greinacher A. Heparin-induced thrombocytopenia and cardiac surgery. Ann. Thorac. Surg. 76 (2003) 638-648
20. Aouifi A., Blanc P., Piriou V., Bastien O.H., Ffrench P., Hanss M., et al. Cardiac surgery with cardiopulmonary bypass in patients with type II heparin-induced thrombocytopenia. Ann. Thorac. Surg. 71 (2001) 678-683
21. Westphal K., Martens S., Strouhal U., Matheis G., Lindhoff-Last E., Wimmer-Greinecker G., et al. Heparin-induced thrombocytopenia type II: perioperative management using danaparoid in a coronary artery bypass patient with renal failure. Thorac. Cardiovasc. Surg. 45 (1997) 318-320
22. Poetzsch B., and Madlener K. Management of cardiopulmonary bypass anticoagulation in patients with heparin-induced thrombocytopenia. In: Warkentin T.E., and Greinacher (Eds). Heparin-induced thrombocytopenia (2003), Marcel Dekker, INC. Basel, New York 531-547